Physician profile
Saksith Smithason
NPI 1154651867
$1,487.48
in general payments reported to CMS, 2019-2025
18 companies · $43.54 in 2025
The $43.54 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $835 · 2021: $18.07 · 2022: $100 · 2023: $104 · 2024: $34.75 · 2025: $43.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $182.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $737.04 | 2020 | |
| Amgen INC. | $143.07 | 2019-2021 | |
| Boston Scientific Corporation | $119.04 | 2022-2023 | |
| Csl Behring | $101.12 | 2019 | |
| Orthofix Medical, INC. | $89.75 | 2019-2025 | Cervical-Stim, Physio-Stim, Spinal-Stim |
| Portola Pharmaceuticals, LLC | $50.03 | 2019 | |
| Si-Bone, INC. | $46.13 | 2020-2024 | |
| Teva Pharmaceuticals USA, INC. | $27.77 | 2020-2022 | |
| Abbott Laboratories | $25.65 | 2019 | |
| Abbvie INC. | $24.89 | 2019 | |
| Kci USA, INC. | $20.37 | 2022 | |
| Intrinsic Therapeutics | $18.73 | 2025 | Barricaid Acd (Annular Closure Device) |
| Avanir Pharmaceuticals, INC. | $16.97 | 2020 | |
| Djo, LLC | $14.57 | 2020 | |
| Theragen, INC. | $13.87 | 2024 | Actastim-S |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $13.81 | 2020 | |
| Neurelis, INC. | $12.69 | 2020 | |
| Zimmer Biomet Holdings, INC. | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saksith Smithason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.